"The Bronchiectasis Patient Conference gives patients a platform to share their experiences.”
Justine from our Bronchiectasis PAG is co-chairing the ELF #Bronchiectasis2025 Patient Conference and representing the patient perspective.
🚨 Register: https://t.co/0caur3er6j
Exciting to see our preprint on endotypes of bronchiectasis patients with PA and how to reduce inconsistencies in ciprofloxacin trials. Awesome team effort including the @UoDMedicine respiratory research group, @ProfJDChalmers
https://t.co/H9QerPOUXm
🌏 #WBConf25
📍 Brisbane, Australia
📅 14–17 July 2025
✨ Registration opens soon!
✅ Get a discount on your registration OR
✅ Referral discounts for you & a colleague!
👉 Send us an email mentioning your interest in the special discount for WBC2025
#Bronchiectasis
What is the future for inhaled antibiotics?
New paper just published from the brilliant @emma_d_johnson explores inhaled antibiotic trials, future directions and how these treatments might fit into an evolving landscape
https://t.co/5WD1QCpIQe
Just out @accpchest
A detailed study of Aspergillus disease in the EMBARC registry
ABPA, Asp sensitization and raised Asp IgG all linked to poorer outcomes in bronchiectasis.
Testing across Europe is patchy!
👏👏 @_JenPollock@UoDMedicine@EuroRespSoc
https://t.co/Vmxe4uoS8D
New paper just out in @accpchest
A blood biomarker for NTM infection in people with bronchiectasis! Anti-GPL core antibodies show high accuracy to identify NTM infection in BE patients
Congratulations @hayoungcc@Shoemelia@MereteLong@UoDMedicine
https://t.co/7Fyv8CIKLV
Meet our newest @ATS_PITB#EarlyCareer 🌟Highlight🌟, Dr. Jennifer Pollock! She studies eosinophilic #bronchiectasis endotype 🧬, and in her free time, she likes to 🧶 knit baby hats! Her advice to trainees? Don't be afraid to network, even if it feels a little awkward at first!
ERJOR @ERSpublications: Are psychological comorbidities common and related to HRQoL and clinical outcomes in #bronchiectasis patients? Check out an interesting study by @tdster23 et al. from the BronchUK cohort!
https://t.co/5gBzV2CunE
Reflecting on an incredible #ERS2024 with great science and wonderful friends. All the more sweet after some difficult times in 2023.
“Success is not final, failure is not fatal, it’s the courage to continue that counts”
So excited about the future with these amazing people
We’d love to understand what healthcare professionals know about Bronchiectasis. Please help us by taking a few minutes to complete this survey. @EuropeanLung@EMBARCnetwork@EuroRespSoc#ERS2024
For most of the past 3 decades, bronchiectasis has been treated as an infectious disease.
A new Review in @LancetRespirMed argues that bronchiectasis is primarily a chronic inflammatory disease and introduces a novel concept of disease activity: https://t.co/GPQ88Wi6l4
End of another busy day at #WBConf24 in Dundee with some fantastic sessions. Help us take bronchiectasis research to the next level by becoming part of EMBARC. Find us outside LT3 tomorrow to get involved and join the registry.